Solventum (formerly 3M Health Information Systems)

The incumbent coding and CDI platform, adding autonomous coding

Our take

Solventum is the healthcare company spun off from 3M in April 2024 (NYSE: SOLV), and its Health Information Systems segment is the former 3M HIS business behind the 360 Encompass platform. 360 Encompass combines computer-assisted coding, clinical documentation integrity, and auditing in one system, and the newer 360 Encompass Autonomous Coding System finalizes qualified outpatient visits with no coder touch, backed by more than a million proprietary coding rules. Buyers are hospitals and health systems, plus RCM services firms and payers that license its grouping and payment methodologies.

Solventum is the incumbent in the mid revenue cycle: its coding, grouper, and CDI tools sit inside most large US hospitals, which gives it distribution that startups lack. Its 2026 partnership with Ensemble Health Partners to deploy autonomous coding across all specialties signals the strategy of converting that installed base to automation. The segment posted 4.7% organic growth with management citing faster-than-expected autonomous coding adoption. The buyer caveat is pace: this is a large public company mid-restructuring, and its automation depth on any given chart mix should be benchmarked against newer entrants like Arintra, CodaMetrix, and Fathom.

What it does

360 Encompass computer-assisted coding and CDI platform
Autonomous coding that finalizes 80%+ of qualified outpatient charts
Over 1 million proprietary coding rules as guardrails
Grouping, reimbursement, and quality methodologies (MS-DRG, APR-DRG)
Semi-autonomous fallback workflow for complex visits

Where it's strong

Decades of coding content, terminologies, and payment methodologies that startups have to rebuild from scratch.
Already installed in most large US hospitals, so autonomous coding can be turned on without a new vendor relationship.
Public-company stability and a compliance track record that eases legal and audit review.

What buyers should weigh

Autonomous coding is a newer bolt-on to a legacy platform; automation rates and chart eligibility trail some startup claims, so test on your own case mix.
Enterprise contracts are large and multi-year, with less pricing flexibility than per-chart startup models.
The company is mid-restructuring after the 3M spinoff, with a $500M cost-cutting program that buyers should watch for support impact.

Latest

In 2026 Ensemble Health Partners announced a strategic partnership with Solventum to run autonomous coding at scale across all medical specialties, and Solventum reported 4.7% organic growth in Health Information Systems.